Responding Safely to Medicines Errors and Near Misses in Older People’s Care
Medicines errors and near misses are among the most scrutinised issues in older people’s services. What commissioners and inspectors focus on is not the absence of mistakes, but how providers respond when something goes wrong. A calm, structured response protects people, supports staff and strengthens systems. This article forms part of the wider Knowledge Hub and sits within the Medicines, Frailty, Falls & Safety topic area.
Immediate response: contain risk before investigating cause
The first priority following a medicines error or near miss is safety, not blame or root cause analysis. Staff must be clear on immediate actions, including checking the person’s condition, monitoring for symptoms, and seeking clinical advice where required.
Day-to-day practice should include clear guidance on when to contact a GP, pharmacist, NHS 111 or emergency services, and how to reassure the individual and their family. Prompt, calm action reduces harm and demonstrates competent leadership.
Recording medicines errors and near misses accurately
Accurate, factual recording is essential. Records should clearly state what was intended, what actually occurred, and what actions were taken, without speculation or defensiveness. This includes documenting timing, dosage, the medicine involved and any observed effects.
Near misses should be recorded with the same seriousness as errors. They provide valuable intelligence about system weaknesses, workload pressures or unclear instructions before harm occurs.
Operational example 1: Missed dose identified during routine audit
Context: A senior staff member identifies a missed morning dose during a routine MAR chart audit.
Support approach: The individual is checked for symptoms and found to be well.
Day-to-day delivery detail: The GP is informed, reassurance is provided to the individual, and the incident is recorded as a missed dose with no adverse outcome.
How effectiveness is evidenced: Audit records show prompt action, clinical advice sought, and follow-up supervision with the staff member involved.
Operational example 2: PRN medicine administered without clear documentation
Context: PRN medication is given, but the indication and outcome are not clearly documented.
Support approach: The manager reviews the PRN protocol and identifies ambiguity.
Day-to-day delivery detail: The PRN protocol is clarified, staff receive refresher guidance, and expectations for documentation are reinforced.
How effectiveness is evidenced: Subsequent audits show clearer records and reduced variation in PRN use.
Operational example 3: Repeated near misses during busy medication rounds
Context: Several near misses occur during early morning medication rounds.
Support approach: Leadership reviews staffing levels, interruptions and task sequencing.
Day-to-day delivery detail: Medication rounds are restructured, protected time is introduced, and interruptions are minimised.
How effectiveness is evidenced: Near miss reporting decreases and staff confidence improves.
Safeguarding considerations and escalation
Not all medicines errors are safeguarding concerns. However, repeated errors, unsafe practice or failure to follow guidance may meet safeguarding thresholds. Providers must demonstrate proportionate decision-making, timely escalation and external referrals where required.
Learning reviews and system improvement
Learning reviews should focus on understanding how systems failed rather than attributing blame. Reviews should identify contributing factors such as workload, unclear protocols or training gaps, and result in clear, tracked actions.
Governance systems must evidence that learning leads to real change, not just paperwork.
Commissioner expectation
Commissioners expect transparent reporting, prompt response, learning-led improvement and assurance that medicines errors are addressed systematically.
Regulator / Inspector expectation (e.g. CQC)
Inspectors expect openness, safety-first responses, staff support and governance systems that turn incidents into safer, more reliable practice.
Key takeaway
Strong medicines governance is demonstrated not by the absence of errors, but by consistent, proportionate responses that protect people and continuously improve systems.